News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Prosarix and ChemOvation Enter into Co-development and Licensing Agreement



7/31/2007 12:00:38 PM

Cambridge, UK, July 31st 2007 — Prosarix Ltd., the drug discovery company specialising in computational screening and design, and ChemOvation Ltd, a leading provider of medicinal chemistry services, today announced a co-development and licensing agreement relating to the further development of a compound series against an undisclosed GPCR target discovered using the Prosarix technology.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES